51% of pharmaceutical firms keen on their drug sales related information

Published: 2012-05-08 06:56:00

Updated: 2012-05-08 06:56:00

50.9 percent of domestic and foreign drug firms are keenly interested in acquiring specific information showing the individual sales records of their drugs in each region, the government report said Monday.

According to the Health Insurance Review and Assessment Service, 108 companies requeste...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK